Clinical Trials in Ohio

Showing 18581-18600 of 20,938 trials

Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer

NCT00006228

Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Interleukin-2 may stimulate a person's white blood cells to kill breast cancer cells. Phase II trial to study the effectiveness of trastuzumab plus interleukin-2 in treating patients who have metastatic breast cancer that has not responded to previous trastuzumab therapy.

HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more

National Cancer Institute (NCI)37 participantsStarted Jul 2000

Columbus, Ohio, United States

COMPLETEDNA32 miles

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

NCT00000873

This study examines the effects of an infant formula containing increased calories, as compared to commercial formulas, when given during the first 6 months of life. It will examine effects on growth, disease progress, immune system, and quality of life of infected infants. HIV disease in infants often leads to nutritional deficiencies. Providing increased nutrition early in their lives may help the quality of life of children who contract HIV from their mothers.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)2,400 participants

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +69 more locations

Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

Find Trials by Condition in Ohio

Use of a Multimedia Presentation for Informed Consent

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

A Comparison of Two Anti-HIV Treatment Plans

A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols

A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly

Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Zidovudine and Lamivudine Given Once Versus Twice Daily

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients